Diabetes mellitus decreases hippocampal release of neurotransmitters: An in vivo microdialysis study of awake, freely moving rats

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 17, Issue 3, 2004, Pages 128-136

  Yamato, T ^a   Misumi, Y ^a   Yamasaki, S ^a   Kino, M ^a   Aomine, M ^a  

^a NAKAMURA GAKUEN UNIVERSITY   (Japan)

Author keywords

Diabetes mellitus; Dopamine; In vivo microdialysis; Rat hippocampus; Serotonin

Indexed keywords

DOPAMINE; MONOAMINE; NEUROTRANSMITTER; SEROTONIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; HIPPOCAMPUS; IN VIVO STUDY; MALE; MICRODIALYSIS; MONOAMINE RELEASE; MONOAMINERGIC SYSTEM; NEUROENDOCRINE DISEASE; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RAT STRAIN; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE; STATISTICAL SIGNIFICANCE; STRAIN DIFFERENCE; STREPTOZOCIN DIABETES; WAKEFULNESS;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DOPAMINE; HIPPOCAMPUS; INSULIN; MALE; MICRODIALYSIS; NEUROTRANSMITTER AGENTS; RATS; RATS, WISTAR; SEROTONIN;

ANIMALIA; KOBUS KOB;

EID: 4344702955     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Marshall J.F.: Further analysis of the resistance of the diabetic rat to D-amphetamine. Pharmacol. Biochem. Behav. 8: 281-286, 1978.
2. Hilakivi-Clarke L.A., Wozniak K.M., Duracan M.J., Linnoila M.: Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression. Physiol. Behav. 48: 429-433, 1990.
3. Tannenbaum G.S.: Growth hormone secretory dynamics in streptozotocin diabetes: evidence of a role for endogenous circulating somatostatin. Endocrinology 108: 76-82, 1981.
4. Katayama S., Brownscheidle C.M., Wootten A.F., Lee J.B., Shimaoka K.: Absent or delayed preovulatory luteinizing hormone surge in experimental diabetes mellitus. Diabetes 33: 324-327, 1984.
5. Lustman P.J., Amado H., Wetzel R.D.: Depression in diabetics: a critical appraisal. Comp. Psychiatry 24: 65-74, 1983.
6. Rodin G.M.: Psychological aspects of diabetes mellitus. Am. J. Psychiatry 28: 219-223, 1983.
7. Lackovic Z., Salkovic M., Kuci Z., Relja M.: Effect of long-lasting diabetes mellitus on rat and human brain monoamines. J. Neurochem. 54: 143-147, 1990.
8. Trulson M.E., Himmel C.D.: Effects of insulin and streptozotocin-induced diabetes on brain norepinephrine metabolism in rats. J. Neurochem. 44: 1873-1876, 1985.
9. Bitar M.S., Koulu M., Rapport S.I., Linnoila M.: Diabetes-induced alterations in brain monoamine metabolism in rats. J. Pharmacol. Exp. Ther. 236: 432-437, 1986.
10. Chu P.C., Lin M.T., Shian L.R., Leu S.Y.: Alterations in physiologic functions and in brain monoamine content in streptozotocin-diabetic rats. Diabetes 35: 484-485, 1986.
11. Trulson M.E., Jacoby J.H., Mackenzie R.G.: Streptozotocin-induced diabetes reduces brain serotonin synthesis in rats. J. Neurochem. 46: 1068-1072, 1986.
12. Kwok R.P., Juorio A.V: Facilitating effect of insulin on brain 5-hydroxytryptamine metabolism. Neuroendocrinology 45: 267-273, 1987.
13. Massol J., Martin P., Belon J-P., Puech A.J., Soubrie P.: Helpless behavior (escape deficits) in streptozotocin-diabetes rats: resistance to antidepressant drugs. Psychoneuroendocrinology 14: 145-153, 1989.
14. Lackovic Z., Salkovic M.: Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction. Life Sci. 46: 49-54, 1990.
15. Shimizu H.: Alteration in hypothalamic monoamine metabolism of freely moving diabetic rat. Neurosci. Lett. 131: 225-227, 1991.
16. Jamnicky B., Muck-Seler D., Slijepcevic M.: Favorable effect of tryptophan/insulin treatment on serotonergic imbalance in alloxan diabetic rats. Comp. Biochem. Physiol. 105A: 267-273, 1993.
17. Dunbar J.C., Clough-Helfman C., Barraco R.A., Anderson G.F.: Effect of insulin and clonidine on the evoked release of norepinephrine and serotonin from the nucleus tractus solitarius of the diabetic rat. Pharmacology 51: 370-380, 1995.
18. Ohtani N., Ohta M., Sugano T.: Microdialysis study of modification of hypothalamic neurotransmitters in streptozotocin-diabetic rats. J. Neurochem. 69: 1622-1628, 1997.
19. Sandrini M., Vitale G., Vergoni A.V., Ottani A., Bertolini A.: Streptozotocin-induced diabetes provokes changes on serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brain. Life Sci. 60: 1393-1397, 1997.
20. Thorre K., Chaouloff F., Sarre S., Meeusen R., Ebinger G., Michotte Y.: Differential effects of restraint stress on hippocampal 5-HT metabolism and extracellular levels of 5-HT in streptozotocin-diabetic rats. Brain Res. 772: 209-216, 1997.
21. Vakov L.: Studies on the basal blood serotonin level in patients with diabetes mellitus. Vutr. Boles 23: 79-84, 1984.
22. Pietraszek M.H., Takada Y., Takada A., Fujita M., Watanabe I., Taminato A., Yoshime T.: Blood serotonergic mechanisms in type 2 (non-insulin-dependent) diabetes mellitus. Thromb. Res. 66: 765-774, 1992.
23. Yang Y.F., Lin M.T.: Brain serotonin depletion attenuates diabetogenic effects of streptozotocin. Am. J. Physiol. 268: E839-E844, 1995.
24. Kwok R.P., Walls E.K., Juorio A.V.: The concentration of dopamine, 5-hydroxytryptamine, and some of their acid metabolites in the brain of genetically diabetic rats. Neurochem. Res. 10: 611-616, 1985.
25. King T.S., Rohrbach D.H.: Reduced aminergic synthesis in the hypothalamus of the infertile, genetically diabetic (C57BL/KsJ-db/db) male mouse. Brain Res. 81: 619-625, 1990.
26. Shimizu H., Bray G.A.: Hypothalamic monoamines measured by microdialysis in rats treated with 2-deoxy-glucose or d-fengluramine. Physiol. Behav. 46: 799-808, 1989.
27. Mason J.W.: A historical review of the stress field. J. Hum. Stress 1: 22-36, 1975.
28. De Kloet E.R.: Brain corticosteroid receptor balance and homeostatic control. Frontiers Neuroendocrinol. 12: 95-164, 1991.
29. Chaouloff F.: Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res. Rev. 18: 1-32, 1993.
30. Yamato T., Misumi Y., Tsuji M., Aomine M.: The hippocampal serotonin and dopamine levels decrease in spontaneously diabetic and STZ-diabetic rats. Jpn. J. Physiol. 50 (Suppl): S232, 2000.
31. Machida K., Doi K., Kaburaki K., Sugano S.: Electrocardiographic findings of WBN/Kob rats. Lab. Anim. 24: 288-291, 1990.
32. Tsuchida K., Watajima H., Otomo S.: Calcium current in rat diabetic ventricular myocytes. Am. J. Physiol. 267: H2280-H2289, 1994.
33. Yamato T., Yamasaki S., Misumi Y., Kino M., Obata T., Aomine M.: Postrest contraction in the ventricular papillary muscle of spontaneously diabetic WBN/Kob rat. Exp. Anim. 50: 19-31, 2001.
34. Paxinos G., Watson C.: The Rat Brain in Stereotaxic Co-ordinates. Academic Press, Sydney, 1986.
35. Yamato T., Yamasaki S., Misumi Y., Kino M., Obata T., Aomine M.: Modulation of the stress response by coffee: an in vivo microdialysis study of hippocampal serotonin and dopamine of freely moving rats. Neurosci. Lett. 332: 87-90, 2002.
36. Benveniste H., Drejer J., Shousbrou A., Diemer N.H.: Regional cerebral glucose phosphorylation and blood flow after insertion of a microdialysis fibre through the dorsal hippocampus in the rat. J. Neurochem. 49: 729-734, 1987.
37. Matos F.F., Rollema H., Basbaum A.I.: Characterization of monoamine release in the lateral hypothalamus of awake, freely moving rats using in vivo microdialysis. Brain Res. 528: 39-47, 1990.
38. Westerink B.H.C.: Brain microdialysis and its application for the study of animal behavior. Behav. Brain Res. 70: 103-124, 1995.
39. Crandall E.A., Gillis M.A., Fernstrom J.D.: Reduction in brain serotonin synthesis rate in streptozotocin-diabetic rats. Endocrinology 109: 310-312, 1981.
40. 3H]spiroperidol binding in streptozotocin-diabetic rats. J. Neurochem. 40: 1456-1459, 1983.
41. Kulikov A.V., Arkhipova L.V., Tretyak T.M., Bragin A.G.: Serotonin and norepinephrine content in brain structures of rats with experimental and transplantation-compensated diabetes. J. Hirnforch. 27: 495-499, 1986.
42. Bellush L.L., Reid S.G.: Altered behavior and neuro-chemistry during short-term insulin withdrawal in streptozotocin-induced diabetic rats. Diabetes 40: 217-222, 1991.
43. Ding A., Nitsch R., Hoyer S.: Changes in brain monoaminergic neurotransmitter concentrations in rat after intracerebroventricular injection of streptozotocin. J. Cereb. Blood Flow Metab. 12: 103-109, 1992.
44. Murzi E., Contreras Q., Teneud L., Valecillos B., Parada M.A., De Parada M.P., Hernandez L.: Diabetes decreases limbic extracellular dopamine in rats. Neurosci. Lett. 202: 141-144, 1996.
45. MacKenzie R.G., Trulson M.E.: Effects of insulin and streptozotocin-induced diabetes on brain tryptophan and serotonin metabolism in rats. J. Neurochem. 30: 205-211, 1978.
46. Crandall E.A., Fernstrom J.D.: Effects of experimental diabetes on the levels of aromatic and branched-chain amino acids in rat blood and brain. Diabetes 32: 222-230, 1983.
47. Sadler E., Wyner M., Buterbaugh G.G.: Effect of streptozotocin-induced diabetes on tryptophan oxygenase activity and brain tryptophan levels in rats. Res. Commun. Chem. Pathol. Pharmacol. 42: 37-50, 1983.
48. Broderick P.A., Jacoby J.H.: Diabetes-related changes in L-tryptophan-induced release of striatal biogenic amines. Diabetes 37: 956-960, 1988.
49. Bradberry C.W., Karasie D.H., Deutch AY., Roth R.H.: Regionally- specific alteration in mesotelencephalic dopamine synthesis in diabetic rats: association with precursor tyrosine. J. Neural Transm. 78: 221-229, 1989.
50. Chaouloff F., Laude D., Merino D., Serrurier B., Baudrie V., Elghozi J.L.: Duration of streptozotocin diabetes influences the response of hypothalamic serotonin metabolism to immobilization stress. Neuroendocrinology 50: 344-350, 1989.
51. Kono T., Takada M.: Dopamine depletion in nigrostriatal neurons in the genetically diabetic rat. Brain Res. 634: 155-158, 1994.
52. Petrisic M.S., Augood S.J., Bicknell R.J.: Monoamine transporter gene expression in the central nervous system in diabetes mellitus. J. Neurochem. 68: 2435-2441, 1997.
53. Curzon G., Fernando J.C.R.: Drugs altering insulin secretion: effects on plasma and brain concentrations of aromatic amino acids and on brain 5-hydroxytryptamine turnover. Br. J. Pharmacol. 601: 401-408, 1977.
54. Manjarrez-Gutierrez G., Herrera-Marquez R., Bueno-Santoyo S., Gonzalez-Ramirez M., Hernandez J.: Changes in brain serotonin biosynthesis in rats with diabetes mellitus induced by streptozotocin induced by streptozotocin: effect of insulin treatment. Rev. Invest. Clin. 52: 509-516, 2000.
55. Saller G., Chiodo L.A.: Glucose suppresses basal firing and haloperidol-induced increases in the firing rate of central dopaminergic neurons. Science 210: 1269-1271, 1980.
56. Bhattacharya S.K., Saraswati M.: Effects of intracerebroventricularly administered insulin on brain monoamines and acetylcholine in euglycaemic and alloxan-induced hyperglycaemic rats. Indian J. Exp. Biol. 29: 1095-1100, 1991.
57. Bitar M.S., Koulu M., Linnoila M.: Diabetes-induced changes in monoamine concentrations of rat hypothalamic nuclei. Brain Res. 409: 236-242, 1987.
58. Weyerer S., Hewer W., Pfeifer-Kurda M., Dilling H.: Psychiatric disorders and diabetes: results from a community study. J. Psychosom. 33: 633-640, 1989.
59. Gavard J.A., Lustman P.J., Clouse R.E.: Prevalence of depression in adults with diabetes. An epidemiological evaluation. Diabetes Care 16: 1167-1178, 1993.
60. Eaton W.W., Armenian H., Gallo J., Pratt L., Ford D.E.: Depression and risk for onset of type II diabetes. Diabetes Care 19: 1097-1102, 1996.
61. Murawski J.B., Chazan B.I., Balodimos M.E., Ryan J.R.: Personally patterns in patients with diabetes mellitus of long duration. Diabetes 17: 259-267, 1970.
62. Mazze R.S., Lucido D., Shamoon H.: Psychological and social correlates of glycemic control. Diabetes Care 1: 360-366, 1984.
63. Linn M.W., Linn B.S., Skyler J.S., Jensen J.: Stress and immune function in diabetes mellitus. Clin. Immunol. Immunopathol. 27: 223-233, 1983.
64. Lustman P.J., Griffith L.S., Clouse R.E., Cryer R.E.: Psychiatric illness in diabetes mellitus. relationship to symptoms and glucose control. J. Nerv. Ment. Dis. 174: 736-742, 1986.
65. Takii M., Uchida Y., Maeda M., Omori Y., Kubo C.: Differences between bulimia nervosa and binge-eating disorder in females with type 1 diabetes: the important role of insulin omission. J. Psychosom. Res. 47: 221-231, 1999.
66. Marshall J.F., Friedman M.I., Heffner T.G.: Reduced anorexic and locomotor-stimulant action of D-amphetamine in alloxan-diabetic rats. Brain Res. 111: 428-432, 1976.